Orientin Reduces the Effects of Repeated Procedural Neonatal Pain in Adulthood: Network Pharmacology Analysis, Molecular Docking Analysis, and Experimental Validation

Background. Premature infants often undergo painful procedures and consequently experience repeated procedural neonatal pain. This can elicit hyperalgesia and cognitive impairment in adulthood. Treatments for neonatal pain are limited. Orientin is a flavonoid C-glycoside that has repeatedly been sho...

Full description

Saved in:
Bibliographic Details
Main Authors: Dong-Dong Guo, Hai-Yan Huang, Hai-E. Liu, Kun Liu, Xing-Jing Luo
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Pain Research and Management
Online Access:http://dx.doi.org/10.1155/2023/8893932
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546706809421824
author Dong-Dong Guo
Hai-Yan Huang
Hai-E. Liu
Kun Liu
Xing-Jing Luo
author_facet Dong-Dong Guo
Hai-Yan Huang
Hai-E. Liu
Kun Liu
Xing-Jing Luo
author_sort Dong-Dong Guo
collection DOAJ
description Background. Premature infants often undergo painful procedures and consequently experience repeated procedural neonatal pain. This can elicit hyperalgesia and cognitive impairment in adulthood. Treatments for neonatal pain are limited. Orientin is a flavonoid C-glycoside that has repeatedly been shown to have pharmacological effects in the past decades. The aim of this study was to systematically explore the effect of orientin on repeated procedural neonatal pain using network pharmacology, molecular docking analysis, and experimental validation. Methods. Several compound-protein databases and disease-protein databases were employed to identify proteins that were both predicted targets of orientin and involved in neonatal pain. A protein-protein interaction (PPI) network was constructed, and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed to explore the potential mechanism of action. Molecular docking analysis was employed to calculate the binding energy and visualize the interactions between orientin and potential target proteins. Finally, a mouse model of repeated procedural neonatal pain was established and orientin was administered for 6 days. The mechanical and thermal pain thresholds were assessed in neonates and adult mice. A Morris water maze was employed to investigate cognitive impairment in adult mice. Results. A total of 286 proteins that were both predicted targets of orientin and involved in neonatal pain were identified. The hub proteins were SRC, HSP90AA1, MAPK1, RHOA, EGFR, AKT1, PTPN11, ESR1, RXRA, and HRAS. GO analysis indicated that the primary biological process (BP), molecular function (MF), and cellular component (CC) were protein phosphorylation, protein kinase activity, and vesicle lumen, respectively. KEGG analysis revealed that the mitogen-activated protein kinase (MAPK) signaling pathway may be the key to the mechanism of action. Molecular docking analysis showed the high binding affinities of orientin for MAPK1, MAPK8, and MAPK14. In mice, orientin inhibited the hyperalgesia in the pain threshold tests in neonates and adult mice and cognitive impairment in adult mice. Immunofluorescence showed that phosphorylated MAPK1 (p-ERK) protein levels in the hippocampus and spinal dorsal horn were downregulated by orientin. Conclusion. The findings suggested that orientin alleviates neonatal pain, and the MAPK signaling pathway is involved.
format Article
id doaj-art-f0eaba0846e14ee085fb265fd91d54ef
institution Kabale University
issn 1918-1523
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Pain Research and Management
spelling doaj-art-f0eaba0846e14ee085fb265fd91d54ef2025-02-03T06:47:33ZengWileyPain Research and Management1918-15232023-01-01202310.1155/2023/8893932Orientin Reduces the Effects of Repeated Procedural Neonatal Pain in Adulthood: Network Pharmacology Analysis, Molecular Docking Analysis, and Experimental ValidationDong-Dong Guo0Hai-Yan Huang1Hai-E. Liu2Kun Liu3Xing-Jing Luo4Department of AnesthesiologyDepartment of CardiovascularDepartment of AnesthesiologyDepartment of AnesthesiologyDepartment of AnesthesiologyBackground. Premature infants often undergo painful procedures and consequently experience repeated procedural neonatal pain. This can elicit hyperalgesia and cognitive impairment in adulthood. Treatments for neonatal pain are limited. Orientin is a flavonoid C-glycoside that has repeatedly been shown to have pharmacological effects in the past decades. The aim of this study was to systematically explore the effect of orientin on repeated procedural neonatal pain using network pharmacology, molecular docking analysis, and experimental validation. Methods. Several compound-protein databases and disease-protein databases were employed to identify proteins that were both predicted targets of orientin and involved in neonatal pain. A protein-protein interaction (PPI) network was constructed, and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed to explore the potential mechanism of action. Molecular docking analysis was employed to calculate the binding energy and visualize the interactions between orientin and potential target proteins. Finally, a mouse model of repeated procedural neonatal pain was established and orientin was administered for 6 days. The mechanical and thermal pain thresholds were assessed in neonates and adult mice. A Morris water maze was employed to investigate cognitive impairment in adult mice. Results. A total of 286 proteins that were both predicted targets of orientin and involved in neonatal pain were identified. The hub proteins were SRC, HSP90AA1, MAPK1, RHOA, EGFR, AKT1, PTPN11, ESR1, RXRA, and HRAS. GO analysis indicated that the primary biological process (BP), molecular function (MF), and cellular component (CC) were protein phosphorylation, protein kinase activity, and vesicle lumen, respectively. KEGG analysis revealed that the mitogen-activated protein kinase (MAPK) signaling pathway may be the key to the mechanism of action. Molecular docking analysis showed the high binding affinities of orientin for MAPK1, MAPK8, and MAPK14. In mice, orientin inhibited the hyperalgesia in the pain threshold tests in neonates and adult mice and cognitive impairment in adult mice. Immunofluorescence showed that phosphorylated MAPK1 (p-ERK) protein levels in the hippocampus and spinal dorsal horn were downregulated by orientin. Conclusion. The findings suggested that orientin alleviates neonatal pain, and the MAPK signaling pathway is involved.http://dx.doi.org/10.1155/2023/8893932
spellingShingle Dong-Dong Guo
Hai-Yan Huang
Hai-E. Liu
Kun Liu
Xing-Jing Luo
Orientin Reduces the Effects of Repeated Procedural Neonatal Pain in Adulthood: Network Pharmacology Analysis, Molecular Docking Analysis, and Experimental Validation
Pain Research and Management
title Orientin Reduces the Effects of Repeated Procedural Neonatal Pain in Adulthood: Network Pharmacology Analysis, Molecular Docking Analysis, and Experimental Validation
title_full Orientin Reduces the Effects of Repeated Procedural Neonatal Pain in Adulthood: Network Pharmacology Analysis, Molecular Docking Analysis, and Experimental Validation
title_fullStr Orientin Reduces the Effects of Repeated Procedural Neonatal Pain in Adulthood: Network Pharmacology Analysis, Molecular Docking Analysis, and Experimental Validation
title_full_unstemmed Orientin Reduces the Effects of Repeated Procedural Neonatal Pain in Adulthood: Network Pharmacology Analysis, Molecular Docking Analysis, and Experimental Validation
title_short Orientin Reduces the Effects of Repeated Procedural Neonatal Pain in Adulthood: Network Pharmacology Analysis, Molecular Docking Analysis, and Experimental Validation
title_sort orientin reduces the effects of repeated procedural neonatal pain in adulthood network pharmacology analysis molecular docking analysis and experimental validation
url http://dx.doi.org/10.1155/2023/8893932
work_keys_str_mv AT dongdongguo orientinreducestheeffectsofrepeatedproceduralneonatalpaininadulthoodnetworkpharmacologyanalysismoleculardockinganalysisandexperimentalvalidation
AT haiyanhuang orientinreducestheeffectsofrepeatedproceduralneonatalpaininadulthoodnetworkpharmacologyanalysismoleculardockinganalysisandexperimentalvalidation
AT haieliu orientinreducestheeffectsofrepeatedproceduralneonatalpaininadulthoodnetworkpharmacologyanalysismoleculardockinganalysisandexperimentalvalidation
AT kunliu orientinreducestheeffectsofrepeatedproceduralneonatalpaininadulthoodnetworkpharmacologyanalysismoleculardockinganalysisandexperimentalvalidation
AT xingjingluo orientinreducestheeffectsofrepeatedproceduralneonatalpaininadulthoodnetworkpharmacologyanalysismoleculardockinganalysisandexperimentalvalidation